
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
AZN | London | GBP | Real-time | |
3LAZ | London | GBP | Real-time | |
3SAZ | London | GBP | Real-time | |
AZNl | BATS Europe | GBP | Delayed | |
AZNs | BATS Europe | SEK | Delayed | |
AZN | NASDAQ | USD | Real-time | |
AZNCF | OTC Markets | USD | Delayed | |
AZNN | Mexico | MXN | Delayed | |
AZN | Stockholm | SEK | Real-time | |
AZN | Frankfurt | EUR | Delayed | |
AZN | TradeGate | EUR | Delayed | |
AZN | Xetra | EUR | Delayed | |
AZNPy | Frankfurt | EUR | Delayed | |
AZN | Buenos Aires | ARS | Delayed |
By Divya Chowdhury and Lisa Pauline Mattackal DAVOS, Switzerland (Reuters) - Although cancer screening and diagnosis was hit by the coronavirus pandemic, resulting advances in medical technology and...
By Divya Chowdhury and Lisa Pauline Mattackal
AstraZeneca (GB:AZN) announced that its COVID-19 vaccine Vaxzevria has been granted approval for use as a third-dose booster shot in adults in the European Union (EU). Approved by the European...
Innoviva Inc (NASDAQ: INVA) has agreed to acquire Entasis Therapeutics Holdings Inc (NASDAQ: ETTX) at $2.20 per share in cash. Innoviva currently owns approximately 60% of the outstanding shares of...
Innoviva Inc (NASDAQ: INVA) has agreed to acquire Entasis Therapeutics Holdings Inc (NASDAQ: ETTX) at $2.20 per share in cash. Innoviva currently owns approximately 60% of the outstanding shares of...
(Reuters) - Drugmaker AstraZeneca (NASDAQ:AZN) said on Monday its COVID-19 vaccine, Vaxzevria, has been approved in the European Union by the bloc's drugs regulator as a third-dose booster in adults...
The European Medicine Agency has approved AstraZeneca plc's (NASDAQ: AZN) COVID-19 vaccine, Vaxzevria, as a third-dose booster in adults following a committee endorsement last week. The vaccine can...
AstraZeneca PLC said Monday that its Covid-19 vaccine has been granted approval in the European Union as a third dose booster for adults.
AstraZeneca's Covid-19 vaccine gets EU approval for third doses
VIDEO: Cambridge-based Astra is a strong example of UK innovation
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review